Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet Chemotherapy.
NMR
UPLC-MS
lipidomics
metabolomics
non-small-cell-lung cancer
overall survival
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
16 Jul 2020
16 Jul 2020
Historique:
received:
09
06
2020
revised:
01
07
2020
accepted:
10
07
2020
entrez:
26
7
2020
pubmed:
28
7
2020
medline:
28
7
2020
Statut:
epublish
Résumé
The metabolic requirements of metastatic non-small cell lung (mNSCLC) tumors from patients receiving first-line platinum-doublet chemotherapy are hypothesized to imprint a blood signature suitable for survival prediction. Pre-treatment samples prospectively collected at baseline from a randomized phase III trial were assayed using nuclear magnetic resonance (NMR) spectroscopy (
Identifiants
pubmed: 32708705
pii: cancers12071926
doi: 10.3390/cancers12071926
pmc: PMC7409233
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NIH HHS
ID : R21-CA-213234
Pays : United States
Organisme : Canadian Cancer Society
ID : 704970
Références
Biochem J. 2012 Feb 1;441(3):789-802
pubmed: 22248339
Respiration. 1995;62(4):223-7
pubmed: 8578019
World J Biol Chem. 2014 Feb 26;5(1):68-74
pubmed: 24600515
J Clin Oncol. 2005 Apr 20;23(12):2831-9
pubmed: 15837997
PLoS One. 2010 May 28;5(5):e10883
pubmed: 20526369
Anal Chem. 2006 Jul 1;78(13):4430-42
pubmed: 16808451
Biochim Biophys Acta. 2013 May;1830(5):3143-53
pubmed: 22995213
Cancer. 1996 Aug 1;78(3):416-21
pubmed: 8697385
Lung Cancer. 2017 Dec;114:70-78
pubmed: 29173770
Lung Cancer. 2011 Nov;74(2):284-92
pubmed: 21411176
J Pharm Biomed Anal. 2014 Nov;100:369-380
pubmed: 25213261
Clin Cancer Res. 2018 May 1;24(9):2100-2109
pubmed: 29437793
Mol Cell. 2016 Jan 21;61(2):210-21
pubmed: 26774282
Oncotarget. 2016 Mar 15;7(11):12904-16
pubmed: 26883203
Cell Metab. 2013 Aug 6;18(2):153-61
pubmed: 23791484
Crit Rev Oncol Hematol. 2017 Apr;112:31-40
pubmed: 28325263
Nat Rev Genet. 2014 May;15(5):293-306
pubmed: 24662220
Oncogenesis. 2016 Jan 25;5:e189
pubmed: 26807644
Cancer Cell. 2015 Feb 9;27(2):211-22
pubmed: 25620030
Nat Protoc. 2007;2(11):2692-703
pubmed: 18007604
Sci Rep. 2015 Feb 25;5:8607
pubmed: 25712604
Lung Cancer. 2010 Apr;68(1):44-50
pubmed: 19559498
Am J Clin Nutr. 2002 Dec;76(6):1244-8
pubmed: 12450889
Future Oncol. 2010 Oct;6(10):1603-24
pubmed: 21062159
Br J Cancer. 2017 Jun 6;116(12):1499-1504
pubmed: 28472819
Metabolomics. 2016;12:58
pubmed: 27073350
Adv Genet. 2010;70:27-56
pubmed: 20920744